Literature DB >> 26033983

Marfan and Sartans: time to wake up!

Julie De Backer1.   

Abstract

Mesh：

Substances：

Year:  2015        PMID： 26033983     DOI： 10.1093/eurheartj/ehv228

Source DB:  PubMed          Journal:  Eur Heart J        ISSN： 0195-668X            Impact factor:   29.983


× No keyword cloud information.
  5 in total

Review 1.  Marfan syndrome; A connective tissue disease at the crossroads of mechanotransduction, TGFβ signaling and cell stemness.

Authors:  Francesco Ramirez; Cristina Caescu; Elisabeth Wondimu; Josephine Galatioto
Journal:  Matrix Biol       Date:  2017-08-04       Impact factor: 11.583

2.  Systems pharmacology-based integration of human and mouse data for drug repurposing to treat thoracic aneurysms.

Authors:  Jens Hansen; Josephine Galatioto; Cristina I Caescu; Pauline Arnaud; Rhodora C Calizo; Bart Spronck; Sae-Il Murtada; Roshan Borkar; Alan Weinberg; Evren U Azeloglu; Maria Bintanel-Morcillo; James M Gallo; Jay D Humphrey; Guillaume Jondeau; Catherine Boileau; Francesco Ramirez; Ravi Iyengar
Journal:  JCI Insight       Date:  2019-06-06

Review 3.  Bicuspid aortic valve related aortopathy.

Authors:  Sina Stock; Salah A Mohamed; Hans-Hinrich Sievers
Journal:  Gen Thorac Cardiovasc Surg       Date:  2017-08-30

4.  The Effect of a Nonpeptide Angiotensin II Type 2 Receptor Agonist, Compound 21, on Aortic Aneurysm Growth in a Mouse Model of Marfan Syndrome.

Authors:  Peter Verbrugghe; Jelle Verhoeven; Marnick Clijsters; Dominique Vervoort; Jarne Schepens; Bart Meuris; Paul Herijgers
Journal:  J Cardiovasc Pharmacol       Date:  2018-04       Impact factor: 3.105

5.  Nicotine Exacerbates TAAD Formation Induced by Smooth Muscle-Specific Deletion of the TGF-β Receptor 2.

Authors:  Changzoon Chun; Xiaoyan Qi; Fen Wang; Kyle B Madrid; Lennon A Saldarriaga; Max R Fisch; Mark L Brantly; Gilbert R Upchurch; Zhihua Jiang
Journal:  J Immunol Res       Date:  2021-10-01       Impact factor: 4.818
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.